Ambiq Micro, a 15-year-old producer of energy-efficient chips for wearable and medical gadgets, closed its first day of buying and selling on Wednesday at $38.53 a share, a 61% improve from the $24 IPO value the corporate set the day prior to this.
The success of the IPO indicators sturdy investor demand within the public marketplace for new small-cap corporations benefiting from AI innovation.
Ambiq closed its first day as a public firm with a valuation of $656 million (excluding worker choices). This represents a big improve from its final personal funding valuation of $450 million in 2023, based on PitchBook.
Ambiq has pitched itself as well-positioned to capitalize on the expansion pushed by AI. “As a result of we’re so low power, we are able to put extra intelligence and extra AI on board” of edge processors, the corporate’s CTO Scott Hanson advised Trendster.
For the three months that ended March 31, Ambiq posted a web lack of $8.3 million in opposition to revenues of $15.7 million, the corporate’s S1 submitting reveals. The Q1 outcomes mark a slight enchancment from the primary quarter of 2024, when the corporate reported a $9.8 million loss on $15.2 million in income.
Kleiner Perkins and EDB Investments, a Singaporean state-backed entity, are the most important exterior backers of Ambiq, based on the submitting.
Wen Hsieh, who was a basic companion at Kleiner Perkins till 2023, first backed Ambiq when the corporate raised its Sequence C in 2014. Hsieh additionally invested in Ambiq after he launched his personal enterprise agency, Matter Enterprise Companions, two years in the past.
Techcrunch occasion
San Francisco
|
October 27-29, 2025
